277 related articles for article (PubMed ID: 28074772)
1. [Nuclear medicine techniques for selective internal radiotherapy of liver cancer].
Staanum PF; Arveschoug AK; Kramer SM; Nielsen JE; Nielsen DT; Ott P; Grønbæk H; Villadsen GE
Ugeskr Laeger; 2017 Jan; 179(1):. PubMed ID: 28074772
[TBL] [Abstract][Full Text] [Related]
2. Is a Technetium-99m Macroaggregated Albumin Scan Essential in the Workup for Selective Internal Radiation Therapy with Yttrium-90? An Analysis of 532 Patients.
Sancho L; Rodriguez-Fraile M; Bilbao JI; Beorlegui Arteta C; Iñarrairaegui M; Moran V; Sangro B
J Vasc Interv Radiol; 2017 Nov; 28(11):1536-1542. PubMed ID: 28916345
[TBL] [Abstract][Full Text] [Related]
3. Can pretreatment hepatic artery perfusion scintigraphy in patients with liver malignancies predict the treatment response of the selective internal radiation therapy with 90Y resin microspheres?
Guney IB; Balli HT; Kucuker KA; Unal I; Kibar M
Diagn Interv Radiol; 2022 Mar; 28(2):156-165. PubMed ID: 35548900
[TBL] [Abstract][Full Text] [Related]
4. Patient selection and activity planning guide for selective internal radiotherapy with yttrium-90 resin microspheres.
Lau WY; Kennedy AS; Kim YH; Lai HK; Lee RC; Leung TW; Liu CS; Salem R; Sangro B; Shuter B; Wang SC
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):401-7. PubMed ID: 20950954
[TBL] [Abstract][Full Text] [Related]
5. A simple method for estimating dose delivered to hepatocellular carcinoma after yttrium-90 glass-based radioembolization therapy: preliminary results of a proof of concept study.
Kokabi N; Galt JR; Xing M; Camacho JC; Barron BJ; Schuster DM; Kim HS
J Vasc Interv Radiol; 2014 Feb; 25(2):277-87. PubMed ID: 24461133
[TBL] [Abstract][Full Text] [Related]
6. SPECT/CT with 99mTc-MAA in radioembolization with 90Y microspheres in patients with hepatocellular cancer.
Hamami ME; Poeppel TD; Müller S; Heusner T; Bockisch A; Hilgard P; Antoch G
J Nucl Med; 2009 May; 50(5):688-92. PubMed ID: 19372479
[TBL] [Abstract][Full Text] [Related]
7. The significance of 99mTc-MAA SPECT/CT liver perfusion imaging in treatment planning for 90Y-microsphere selective internal radiation treatment.
Ahmadzadehfar H; Sabet A; Biermann K; Muckle M; Brockmann H; Kuhl C; Wilhelm K; Biersack HJ; Ezziddin S
J Nucl Med; 2010 Aug; 51(8):1206-12. PubMed ID: 20660379
[TBL] [Abstract][Full Text] [Related]
8. Radioembolization with infusion of yttrium-90 microspheres into a right inferior phrenic artery with hepatic tumor supply is feasible and safe.
Burgmans MC; Kao YH; Irani FG; Dames EL; Teo TK; Goh AS; Chow PK; Tay KH; Lo RH
J Vasc Interv Radiol; 2012 Oct; 23(10):1294-301. PubMed ID: 22922039
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Primary Liver Tumors and Liver Metastases, Part 1: Nuclear Medicine Techniques.
Voutsinas N; Lekperic S; Barazani S; Titano JJ; Heiba SI; Kim E
J Nucl Med; 2018 Nov; 59(11):1649-1654. PubMed ID: 30072501
[No Abstract] [Full Text] [Related]
10. Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours.
Ho S; Lau WY; Leung TW; Chan M; Ngar YK; Johnson PJ; Li AK
Eur J Nucl Med; 1996 Aug; 23(8):947-52. PubMed ID: 8753684
[TBL] [Abstract][Full Text] [Related]
11. Technical solutions to ensure safe yttrium-90 radioembolization in patients with initial extrahepatic deposition of (99m)technetium-albumin macroaggregates.
Barentsz MW; Vente MA; Lam MG; Smits ML; Nijsen JF; Seinstra BA; Rosenbaum CE; Verkooijen HM; Zonnenberg BA; Van den Bosch MA
Cardiovasc Intervent Radiol; 2011 Oct; 34(5):1074-9. PubMed ID: 21191588
[TBL] [Abstract][Full Text] [Related]
12. 90Yttrium PET/MR-based dosimetry after liver radioembolization (SIRT).
Wissmeyer M; Delattre BM; Zaidi H; Terraz S; Ratib O
Clin Nucl Med; 2015 Apr; 40(4):355-7. PubMed ID: 25674869
[TBL] [Abstract][Full Text] [Related]
13. Role of yttrium-90 in the management of unresectable hepatocellular carcinoma and hepatic metastases.
Kousik V; Promila P; Verma R; Gupta A
Indian J Gastroenterol; 2016 May; 35(3):179-85. PubMed ID: 27185180
[TBL] [Abstract][Full Text] [Related]
14. [Selective internal radiotherapy (SIRT) for hepatocellular carcinoma].
Antoch G; Mueller SP; Hamami M; Heusner TA; Ertle J; Hilgard P; Forsting M; Bockisch A
Rofo; 2010 Aug; 182(8):660-70. PubMed ID: 20405369
[TBL] [Abstract][Full Text] [Related]
15. [Radioembolization with (90)Y-microspheres for liver tumors].
Rodríguez-Fraile M; Iñarrairaegui M
Rev Esp Med Nucl Imagen Mol; 2015; 34(4):244-57. PubMed ID: 25911062
[No Abstract] [Full Text] [Related]
16. 99m Tc-Macroaggregated Albumin Liver Lung Shunt Study With Uptake Indicative of Patent Falciform Artery.
Namous N; Kushner D; Dadparvar S
Clin Nucl Med; 2023 Jun; 48(6):510-511. PubMed ID: 36179332
[TBL] [Abstract][Full Text] [Related]
17. Outpatient single-session yttrium-90 glass microsphere radioembolization.
Gates VL; Marshall KG; Salzig K; Williams M; Lewandowski RJ; Salem R
J Vasc Interv Radiol; 2014 Feb; 25(2):266-70. PubMed ID: 24332243
[TBL] [Abstract][Full Text] [Related]
18. Predictive Value of 99mTc-MAA SPECT for 90Y-Labeled Resin Microsphere Distribution in Radioembolization of Primary and Secondary Hepatic Tumors.
Ilhan H; Goritschan A; Paprottka P; Jakobs TF; Fendler WP; Todica A; Bartenstein P; Hacker M; Haug AR
J Nucl Med; 2015 Nov; 56(11):1654-60. PubMed ID: 26315830
[TBL] [Abstract][Full Text] [Related]
19. The effect of catheter-directed CT angiography on yttrium-90 radioembolization treatment of hepatocellular carcinoma.
Rhee TK; Omary RA; Gates V; Mounajjed T; Larson AC; Barakat O; Sato KT; Mulcahy M; Gordon S; Lewandowski RJ; Salem R
J Vasc Interv Radiol; 2005 Aug; 16(8):1085-91. PubMed ID: 16105920
[TBL] [Abstract][Full Text] [Related]
20. Clinical impact of (99m)Tc-MAA SPECT/CT-based dosimetry in the radioembolization of liver malignancies with (90)Y-loaded microspheres.
Garin E; Rolland Y; Laffont S; Edeline J
Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):559-75. PubMed ID: 26338177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
